LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it is scheduled to present at the Collins Stewart Fourth Annual Growth Conference on Wednesday, July 9, 2008. Michael G. Kauffman, M.D., Ph.D., chief executive officer of EPIX, will discuss the company’s business strategy and corporate overview at 8:00 a.m. (ET) at the Mandarin Oriental Hotel in New York City.
